Friday September 18, 2020
Sep-05-2016 16:16TweetFollow @OregonNews
No Cannabis Re-Scheduling, And Now Kratom TooVeselina Dzhingarova Cannabis De-Classified
Now it will sit idly alongside Cannabis, and the research stops there.
(SALEM, Ore.) - As you all will know, the United States Drug Enforcement Agency failed to re-schedule Cannabis at the Federal Level last month.
For many years, Cannabis has been Schedule 1, alongside cocaine and heroin. Despite being used as medicine all over the United States, and the world over, Cannabis is deemed at the federal level to have no medicinal value.
Not only does this make the plant difficult to access for many of the people who depend upon it as medicine, especially in states where it is not publicly sold, it also makes Cannabis very difficult to research.
New innovations which could be based on the bouquet of cannabinoids, new ways of using the plant in practice and culture, all these are put on hold as the US continues to maintain its draconian policy.
This month, Kratom joins Cannabis at schedule 1.
You may not be familiar with Kratom. It is much less popular and culturally known than Cannabis, but it shares much of Cannbis’s potential for valuable medical applications, despite the DEA having determined that it has no research value or spot in the economy.
This is frustrating for anyone who understands the value of remarkable psychoactive chemicals native to plants. It’s also disturbing for anyone who currently depends upon Kratom for any of its powerful effects.
Kratom, heretofore bought and sold more or less legally in the United States, is a powerful painkiller, with some interesting psychoactive effects besides.
Kratom is a powderized leaf from South-Central Asia. It has been used for many generations in places like Indonesia, where the leaves are used to make a tea, or prepared various other ways.
As a natural pain-killer, Kratom has many of the same psychoactive properties of drugs like prescription opiates. But in its unrefined form, the drug poses far less risk to the user than, say, a month’s supply of Oxycontin. Though dependency can emerge among habitual users, Kratom is much more difficult to become dependent upon.
For one, it tastes terrible. The only way to ingest the unrefined product (still the only way to buy the drug in the United States, except for poor “concentrates” and other undeveloped derivatives) is in powdered form, by mouth.
Most people have to consume several grams of the stuff per session. The hydrophobic plant matter is very difficult to mix into water, and then extremely unpalatable if swallowed.
Bitter to a degree most people have not tasted, it’s just very hard to choke down. Taken within capsules, the user will have to swallow more than a dozen pills at a time, “burping” up the taste in the minutes following consumption.
But the pain relieving effects are real. Similar to prescription pain killers in some ways, the effects last for a few hours, then recede.
Mental clarity, imaginative function change, and other subjective psychological effects are often reported, prompting some users to say that Kratom is like a mix of Cannabis and Prescription pain killers, just more reserved than both.
If that sounds good to you, it’s because it is. Kratom has a host of potential benefits, and is currently used by many opiate dependent persons to ween themselves off the more harmful drugs.
And yet, kratom is reserved to Schedule 1, where it may now go without research and practical application alongside Cannabis.
Source: Veselina Dzhingarova, special to Salem-News.com
Articles for September 5, 2016 |